Date
- Thursday, 21 June 2018, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
The European Medicines Agency, the Japanese Pharmaceuticals and Medical Devices Agency and the United States' Food and Drug Administration co-organised this workshop to discuss the development of antibiotics for children. This provides an opportunity for international regulators to explore with medicine developers, clinicians and clinical trial investigators, clinical development plans that would allow for the timely development of antibiotics for children and discuss a regulatory pathway for their approval.